April 17th 2025
The positive topline data from the phase 3 ACHIEVE-1 trial suggest the small molecule GLP-1 mimetic could compete with blockbuster weekly injectables for reducing weight, A1c.
Concurrent Management of Achalasia and Morbid Obesity
The development of a standardized treatment that simultaneously addresses achalasia and obesity is becoming more imperative as obesity becomes epidemic in the US. Here’s a case in point.
What's to Blame for Variable Home BP in Patients With Diabetes?
March 7th 2014Here: factors that can affect home BP readings . . .when to start antiretroviral therapy . . . coping strategies for the challenges of aging . . . triggers to avoid in hyperthyroid patients . . . insights into causes of childhood obesity.